Fielmann (FIE) Q3 2024 earnings summary

Executive summary

• Achieved 13% sales growth in the first nine months, driven by 5% organic growth and 8% from US acquisitions.

• Expanded Eye Health Services to about 400 stores, serving over 70,000 customers.

• Maintained price leadership and increased market share in key European countries despite economic headwinds.

Financial highlights

• Consolidated sales rose to €1.69 billion in the first nine months, up from €1.50 billion year-over-year.

• Adjusted EBITDA increased by 13% to €379 million, with a stable group margin of 22.4%.

• US acquisitions contributed €127 million in sales, up from €9 million in the prior year.

Outlook and guidance

• FY2024 consolidated sales expected at approximately €2.3 billion, including six months of Shopko Optical.

• Profitability guidance remains consistent with previous half-year outlook.